erythromycin has been researched along with Liver Cirrhosis in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (35.29) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, P; Arora, V; Benjamin, J; Choudhary, A; Jamwal, KD; Joshi, YK; Kumar, G; Maiwall, R; Sarin, SK; Vijayaraghavan, R | 1 |
| Botargues, JM; Brullet Benedi, E; Calvet Calvo, X; Campo Fernández de Los Ríos, R; Cánovas Moreno, G; Feu Caballé, F; Fort Martorell, E; Gallach Montero, M; García-Iglesias, P; Gené Tous, E; Hidalgo Rosas, JM; Lago Macía, A; Nieto Rodríguez, A; Papo Berger, M; Planella de Rubinat, M; Saló Rich, J; Villanueva Sánchez, C | 1 |
| Chalasani, N; Ghabril, M; Gorski, JC; Hall, SD; Juluri, R; Kim, S; Thong, N; Vuppalanchi, R | 1 |
| Malnick, SD; Melzer, E | 1 |
| Américo, MF; Caramori, CA; Corá, LA; da Silva Yamashiro, F; Miranda, JR; Romeiro, FG; Silva, GF | 1 |
| De Martin, S; Orlando, R; Padrini, R; Palatini, P; Piccoli, P | 1 |
| Collet, AM; Eissinger, F; Laselve, L; Moncharmont, D; Pinot, JJ; San Marco, JL | 1 |
| Barre, J; Dhumeaux, D; Houin, G; Rosenbaum, J; Tillement, JP; Zini, R | 1 |
| Collier, D; Shaeffer, MS; Sorrell, MF | 1 |
| Carlà, V; Crispo, A; Fallani, S; Mazzei, T; Novelli, A; Periti, P; Surrenti, C; Surrenti, E | 1 |
| Biagini, MR; Cassetta, MI; Conti, S; Fallani, S; Mazzei, T; Novelli, A; Surrenti, C; Surrenti, E | 1 |
| Armenian, B; Burckhardt, B; De Peyer, R; De Saussure, P; Frossard, JL; Giostra, E; Hadengue, A; Ory, G; Queneau, PE; Spahr, L | 1 |
| Gromashevskaia, LL; Kasatkina, MG; Kudriashova, EIu; Neborachko, VS; Vovk, AD | 1 |
| Barre, J; Deforges, L; Dhumeaux, D; Houin, G; Mallat, A; Rosenbaum, J; Tillement, JP | 1 |
| Hirasawa, K | 1 |
| Bottone, EJ; McCarthy, LR | 1 |
| Altmann, G; Halkin, H; Shacked, IJ | 1 |
4 trial(s) available for erythromycin and Liver Cirrhosis
| Article | Year |
|---|---|
Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients.
Topics: Critical Illness; Enteral Nutrition; Erythromycin; Humans; Intensive Care Units; Liver Cirrhosis; Metoclopramide | 2022 |
Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Anti-Bacterial Agents; C-Reactive Protein; Dose-Response Relationship, Drug; Double-Blind Method; Erythromycin; Female; Hepatic Encephalopathy; Humans; Length of Stay; Liver Cirrhosis; Male; Middle Aged; Neomycin; Treatment Outcome | 2013 |
Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.
Topics: Adult; Anesthetics, Local; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Erythromycin; Humans; Lidocaine; Liver Cirrhosis; Male; Protein Synthesis Inhibitors | 2003 |
Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial.
Topics: Adult; Aged; Double-Blind Method; Endoscopy, Digestive System; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hematemesis; Humans; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged; Time Factors | 2002 |
13 other study(ies) available for erythromycin and Liver Cirrhosis
| Article | Year |
|---|---|
Management of non variceal upper gastrointestinal bleeding: position statement of the Catalan Society of Gastroenterology.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Anticoagulants; Biomarkers; Combined Modality Therapy; Comorbidity; Contraindications, Drug; Crystalloid Solutions; Disease Management; Endoscopy, Gastrointestinal; Erythrocyte Transfusion; Erythromycin; Helicobacter Infections; Helicobacter pylori; Hemostatic Techniques; Humans; Hypotension; Intubation, Gastrointestinal; Isotonic Solutions; Liver Cirrhosis; Peptic Ulcer Hemorrhage; Physical Examination; Recurrence; Risk Factors; Vitamin K | 2017 |
Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
Topics: Administration, Oral; Anti-Bacterial Agents; Cytochrome P-450 CYP3A; Electrocardiography; Erythromycin; Humans; Intestinal Mucosa; Liver Cirrhosis; Long QT Syndrome; Portasystemic Shunt, Transjugular Intrahepatic; Risk Factors | 2011 |
Compromise of patient safety in research report.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Liver Cirrhosis; Long QT Syndrome; Portasystemic Shunt, Transjugular Intrahepatic | 2012 |
[Iatrogenic ergotism. Responsibility of an ergotamine tartrate-erythromycine propionate association (author's transl)].
Topics: Adult; Drug Therapy, Combination; Ergotamine; Ergotamines; Ergotism; Erythromycin; Humans; Ischemia; Leg; Liver Cirrhosis; Male | 1982 |
Decreased alpha 1-acid glycoprotein in liver cirrhosis: consequences for drug protein binding.
Topics: Adult; Erythromycin; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Orosomucoid; Protein Binding | 1984 |
Interaction between FK506 and erythromycin.
Topics: Adult; Drug Interactions; Erythromycin; Humans; Liver Cirrhosis; Liver Transplantation; Male; Tacrolimus | 1994 |
Pharmacokinetics of azithromycin in patients with impaired hepatic function.
Topics: Adult; Aged; Azithromycin; Erythromycin; Female; Half-Life; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Tissue Distribution | 1993 |
Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Erythromycin; Female; Humans; Liver Cirrhosis; Macrolides; Male; Metabolic Clearance Rate; Middle Aged | 1999 |
[Excretion of bile acids in feces in pathology of the liver and intestines].
Topics: Bile Acids and Salts; Dysentery; Erythromycin; Feces; Furazolidone; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Prednisolone | 1990 |
Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity.
Topics: Adult; Erythromycin; Female; Humans; Injections, Intravenous; Kinetics; Liver; Liver Cirrhosis; Male; Middle Aged; Protein Binding | 1987 |
[Studies on renin-angiotensin system. I. Angiotensinase activities in hepatic disorders].
Topics: Adult; Angiotensin II; Animals; Bile Duct Neoplasms; Biliary Tract Diseases; Blood Pressure; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Chloramphenicol; Endopeptidases; Erythromycin; Female; Gout; Hepatitis; Humans; Hypertension; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Mercaptopurine; Middle Aged; Nephrotic Syndrome; Rats | 1968 |
Bacteremia and endocarditis caused by satelliting streptococci.
Topics: Adult; Ampicillin; Bacteria; Cephalothin; Child; Chloramphenicol; Culture Media; Cysteine; Endocarditis, Subacute Bacterial; Erythromycin; Female; Humans; Lincomycin; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Tetracycline; Thioglycolates; Vancomycin | 1974 |
Brain abscess due to Listeria monocytogenes in a patient with cirrhosis of the liver.
Topics: Angiography; Brain Abscess; Carotid Arteries; Cerebrospinal Fluid; Craniotomy; Erythromycin; Humans; Listeria monocytogenes; Listeriosis; Liver Cirrhosis; Male; Middle Aged; Penicillins | 1971 |